Managing Clinical Investigator Compensation report ( http://www.bharatbook.com/Market-Research-Reports/Managing-Clinical-Investigator-Compensation.html ) presents an essential source in establishing transparent and defensible compensation processes for clinical investigators not only saves money – it is absolutely essential in today’s restrictive pharma landscape. Regulatory groups, legislative bodies and consumer advocacy groups are applying relentless pressure on commercial relationships with physicians, altering and often limiting industry practices. Now the ripple effect is hitting clinical operations. Some investigations in the area have garnered public attention, with more bound to follow. We projects that within five years the same regulatory scrutiny currently on the commercial side will expand to the clinical side. Companies that do not recognize this inevitable reality and formalize their FMV processes today put themselves at great risk for compromised trial results, an audit, financial damage and regulatory scrutiny. Diligence and constant monitoring will go a long way to preventing careless errors and courting potentially dangerous consequences. Managing Clinical Investigator Compensation gives your company what it needs to be proactive and prepare for change while avoiding common pitfalls.
Use the data benchmarks to:
Control costs
Establish current, market based payments to investigators
Develop regulation-proof calculation and documentation methods
Stay current on the latest FMV regulation concerns and trends
Therapeutic Areas Included in Report:
Autoimmune
Cardiology and Thrombosis
CNS/Psychology
Dermatology
Endocrinology
Gastroenterology
Hematology
Infectious Diseases
Medical Devices
Musculoskeletal
Oncology
Respiratory
Women’s Health
Metrics Included in Report:
Managing Clinical Investigator Compensation’s three chapters include compensation data collected from clinical investigators as well as pharmaceutical, biotechnology and medical device companies. Data include breakdowns by phase, therapeutic area and experience.
Investigator Compensation: Industry Data
Percentage of time that companies monitor negotiations between CROs and investigators
Percentage of companies that hire CROs to recruit investigators
Percentage of companies that hire CROs to contract investigators
Percentage of time that CROs handle investigator payments
Percentage of companies with a formal process in place for determining investigator compensation
Percentage of companies that allow primary investigators to concurrently lead clinical trials for other companies
Average years of experience required for primary investigators, by phase
Average years of experience required for primary investigators, by company type and by phase
Investigator Compensation: Investigator Data
Percentage of investigators involved in each type of clinical trial
Number of trials that an average investigator is currently leading, by category
Average number of companies that investigators have run trials for, by years
Years of experience by investigator type (i.e., primary or secondary)
Contact us at:
Bharat Book Bureau
Tel: 91 22 27578668
Fax: 91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Bharat Book Bureau facilitates companies to take the lead of their industry with best practice business strategies and intelligence, through a unique combination of published reports, databases, country reports, company profiles and customized research services. Bharat Book Bureau provides strategic information tools to the executives, business analysts, and knowledge managers that will help them to probe into and support critical, timely business decisions and strategies. Article Source:http://www.articlesbase.com/health-articles/bharatbookcom-clinical-investigator-compensation-by-therapeutic-area-1003448.html